Civetta is a Cambridge, MA based cancer therapeutics company, founded to advance new medicines through small molecule targeting of beta-propeller domains with the goal of developing important therapeutics for cancers and other diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/04/19 | $53,000,000 | Series A |
Deerfield Management Company, L.P. | undisclosed |
